Submissions (2015).

Date Description Download
05/10/2015 FCMA responsed to the draft guidelines of health record keeping
FCMA rejects this proposal as this will place an unfair burden on practitioners (who are allowed to record patient records in Chinese) if English translation is conducted by a NAATI accredited interpreter. In addition, there is the potential for misunderstanding and inaccurate translation of Chinese medicine terminology if the NAATI accredited translator/interpreter does not have background training in Chinese medicine. A NAATI accredited translator/interpreter may actually be worse than a registered, bilingual Chinese medicine practitioner. An alternative suggestion is that the English translation could be provided by another bilingual Chinese medicine practitioner who is registered with the Board. This would mitigate against the risk of incorrect translations occurring and would not place an unfair financial burden on the practitioner.
FCMA responses to guidelines of health record
21/09/2015 FCMA sumbission for Independent Review of the National Registration and Accreditation Scheme for Health Professions
I write on behalf of the Federation of Chinese Medicine & Acupuncture Societies of Australia Ltd (FCMA) in response to a key recommendation from the Independent Review of the National Registration and Accreditation Scheme for Health Professions. This recommendation is that the current national Boards of nine low-regulatory-workload professions including Chinese Medicine Board of Australia be consolidated into one Board, the Health Professions Australia Board. The FCMA is against this recommendation.
FCMA submission Independent Review of NRAS
03/06/2015 FCMA submission for Review of Medicines and Medical Devices Regulation Chapter Nine: Regulation of Complementary Medicines
After reviewing Chapter Nine: Regulation of Complementary Medicines, the FCMA would like to make the following recommendations: Due to the fact that Chinese medicine profession is nationally regulated via statutory regulation, the FCMA recommends that: 1. A separate committee be established solely for Chinese herbal medicines; 2. A different set of criteria be established for the importation of Chinese herbal products; 3. A different set of criteria be established for the evaluation of the level of risk and toxicity of the Chinese herbal medicines. Please visit the link for more details. http://www.health.gov.au/internet/main/publishing.nsf/Content/Expert-Review-of-Medicines-and-Medical-Devices-Regulation
FCMA submission for Review of Medicines